Lexicon Cuts Commercial Operation, Focuses On R&D After FDA Letdown

Pipeline Includes Neuropathic Pain, Cardiomyopathy, Obesity

 
• By Mandy Jackson
  
Lexicon's restructuring plan represents its second round of layoffs this year. (Shutterstock)

More from Financing

More from Scrip